Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : UBS crawled time : 12:00 save search
AbbVie Advances Immunology Pipeline with First Patient Dosed in Global Phase 3 Trial of Upadacitinib (RINVOQ®) in Hidradenitis Suppurativa
Published: 2023-07-24 (Crawled : 12:00) - prnewswire.com
UBS | $28.12 0.04% 0.0% 2.3M
|
Finance
|
| O: 0.85%
H: 0.33%
C: -0.23%
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.48%
H: 0.0%
C: 0.0%
rinvoq abbvie pipeline global immunology trial
Update on the Regulatory Approvals of the Tender Offer: GF Announces Expiration of U.S. Hart-Scott-Rodino Waiting Period
Published: 2023-07-19 (Crawled : 12:00) - prnewswire.com
UBS | $28.12 0.04% 0.0% 2.3M
|
Finance
|
| O: 0.42%
H: 0.19%
C: -0.42%
update
Update on the Regulatory Approvals of the Tender Offer: GF Announced Expiration of U.S. Hart-Scott-Rodino Waiting period
Published: 2023-07-19 (Crawled : 12:00) - globenewswire.com
UBS | $28.12 0.04% 0.0% 2.3M
|
Finance
|
| O: 0.42%
H: 0.19%
C: -0.42%
update
Result of Tender Offer
Published: 2023-07-05 (Crawled : 12:00) - globenewswire.com
AMIGY | $33.465 -3.71% 4.4K
|
Finance and Insurance
|
| O: -1.26%
H: 0.0%
C: -0.75%
UBS | $28.12 0.04% 0.0% 2.3M
|
Finance
|
| O: -1.71%
H: 0.1%
C: -1.14%
Buyer Consortium Led by Recco Control Technology and Dazheng Group Announces Engagement of UBS as Financial Advisor and Reaffirms Non-Binding Indicative Offer of $25 Per Share to Acquire Hollysys
Published: 2022-07-08 (Crawled : 12:00) - prnewswire.com
UBS | $28.12 0.04% 0.0% 2.3M
|
Finance
|
| O: 1.52%
H: 0.22%
C: -0.25%
HOLI | $24.32 -2.29% -2.34% 450K
|
Electronic Technology
|
| O: 3.64%
H: 1.15%
C: -2.3%
acquire control technology group
MINISO Group Announces Pricing of Global Offering
Published: 2022-07-06 (Crawled : 12:00) - prnewswire.com
UBS | $28.12 0.04% 0.0% 2.3M
|
Finance
|
| O: -2.41%
H: 1.62%
C: 1.04%
MNSO | $20.88 1.56% 0.0% 750K
|
Retail Trade
|
| O: 1.38%
H: 8.16%
C: 5.85%
offering group
MINISO Group Launches Global Offering
Published: 2022-06-29 (Crawled : 12:00) - prnewswire.com
UBS | $28.12 0.04% 0.0% 2.3M
|
Finance
|
| O: 0.06%
H: 0.0%
C: -1.15%
MNSO | $20.88 1.56% 0.0% 750K
|
Retail Trade
|
| O: -4.01%
H: 1.55%
C: -6.93%
offering group
LivaNova Announces Early Retirement of $450 Million Term Loan and Executes $125 Million Revolving Credit Facility
Published: 2021-08-16 (Crawled : 12:00) - biospace.com/
UBS | $28.12 0.04% 0.0% 2.3M
|
Finance
|
| O: -0.5%
H: 0.5%
C: 0.47%
LIVN | $52.8 1.79% 1.76% 540K
|
Health Technology
|
| O: -2.23%
H: 3.25%
C: 2.88%
ev
Viridian Therapeutics Appoints Kristian Humer as Chief Financial Officer and Chief Business Officer
Published: 2021-07-26 (Crawled : 12:00) - globenewswire.com
VRDN | $15.17 0.6% 0.59% 580K
|
Health Care and Social Assistan...
|
| O: 1.64%
H: 0.0%
C: -1.78%
UBS | $28.12 0.04% 0.0% 2.3M
|
Finance
|
| O: 0.78%
H: 1.03%
C: 0.81%
Orocobre and Galaxy agree to a proposed A$4B merger of equals, establishing a new force in the global lithium sector
Published: 2021-04-19 (Crawled : 12:00) - globenewswire.com
UBS | $28.12 0.04% 0.0% 2.3M
|
Finance
|
| O: -0.5%
H: 0.37%
C: -0.56%
lithium merge
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.